ArriVent BioPharma Inc. C...

18.74
0.60 (3.31%)
At close: Apr 21, 2025, 10:39 AM

ArriVent BioPharma Common Stock Balance Sheet Statement

Financials in USD. Fiscal year is undefined.
Fiscal Year Q4 2024 Q3 2024 Q2 2024 Q1 2024 Q4 2023 Q3 2023 Q2 2023 Q1 2023 Q4 2022 Q1 2022
Period Ending Dec 31, 2024 Sep 30, 2024 Jun 30, 2024 Mar 31, 2024 Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Mar 31, 2022
74.29M 150.39M 298.67M 317.39M 150.39M 141.36M 157.83M -163.37M 163.37M n/a
144.57M n/a n/a n/a n/a 25M 25M 326.74M n/a n/a
47.68M n/a n/a n/a n/a 106K n/a n/a n/a n/a
126K 2.84M 125K 108K 2.84M 1.96M 82K -163.37M 72K -37.28M
500K 761K 750K 875K 761K 1.09M 258K n/a 500K n/a
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
226.98M 159.97M 308.51M 327.48M 159.97M 179.98M 198.69M 163.37M 182.62M 37.28M
154K 291K 219K 250K 291K 44K 76K n/a 139K n/a
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
47.96M 3.13M 344K 358K 3.13M 2.11M 158K -163.37M 211K -37.28M
274.94M 163.1M 308.86M 327.84M 163.1M 182.09M 198.84M n/a 182.83M n/a
3.78M 4.53M 3.81M 4.1M 4.53M 4.82M 6.46M n/a 3.09M n/a
n/a n/a n/a n/a n/a n/a n/a n/a -1 n/a
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
4.16M 3.35M n/a n/a n/a n/a n/a n/a 2.46M n/a
17.27M 11.62M 12.1M 9.98M 11.62M 10.1M 12.81M n/a 8.36M n/a
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
n/a 304.49M n/a n/a n/a n/a n/a n/a n/a -41.22M
14K 304.67M 98K 138K 177K 304.49M n/a n/a 11K -41.22M
17.29M 316.29M 12.2M 10.12M 11.8M 10.1M 12.81M n/a 8.37M -41.22M
176K 317K 250K 285K 317K 44K 76K n/a 139K n/a
3K n/a 3K 3K n/a 4K 4K n/a 4K n/a
-238.33M -157.84M -197.14M -175.26M -157.84M -136.65M -122.25M n/a -88.51M n/a
-211K n/a 0.00 n/a n/a -4K -4K -85.11M -4K -48.64M
257.65M -153.19M 296.66M 317.72M 151.3M 171.99M 186.03M 174.46M 174.46M 41.22M
192.25M n/a n/a n/a n/a 25.11M 25M 326.74M n/a n/a